Loading...

Benchmark Holdings plc

BMK.L•LSE
HealthcareDrug Manufacturers - Specialty & Generic
£24.00
£-0.19(-0.79%)

Benchmark Holdings plc (BMK.L) Stock Overview

Explore Benchmark Holdings plc’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
-46.68%
↓ 46.68%
Profit Growth
£-0.06
↓ 70.50%
EPS Growth
£-0.06
↓ 68.99%
Operating Margin
-53.08%
↓ 567.78%
ROE
-17.73%
↓ 70.50%
Dividend Yield
0.00%
Analyst Recommendations data is not available for BMK.LAnalyst Recommendations details for BMK.L are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Benchmark Holdings plc, together with its subsidiaries, provides technical services, products, and specialist knowledge that supports the development of food and farming industries in the United Kingdom, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, rest of the Europe, and internationally. The company operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers salmon breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products to the aquaculture market. Benchmark Holdings plc was founded in 2000 and is based in Sheffield, the United Kingdom.

CEO

Mr. Trond Williksen

Employees

800

Headquarters

Benchmark House, Sheffield

Founded

2013

Frequently Asked Questions